Dividends, Recognition for Innovative Technologies, Stock Price Movements, and Schedule of Conference Calls and Earnings - Analyst Notes on Allegion, Medidata, Mettler-Toledo, WebMD, and Fluidigm

NEW YORK, April 22, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Allegion plc (NYSE: ALLE), Medidata Solutions, Inc. (NASDAQ: MDSO), Mettler-Toledo International, Inc. (NYSE: MTD), WebMD Health Corp. (NASDAQ: WBMD) Fluidigm Corporation (NASDAQ: FLDM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1199-100free

--

Allegion plc Analyst Notes 

On April 9, 2014, Allegion plc (Allegion) announced that its Board of Directors has authorized and declared a quarterly dividend in the amount of $0.08 per ordinary share of the Company, which is payable on June 30, 2014 to shareholders of record on June 16, 2014. The full analyst notes on Allegion plc are available to download free of charge at:

http://www.analystsreview.com/1199-ALLE-22Apr2014.pdf

--

Medidata Solutions, Inc. Analyst Notes 

On April 1, 2014, Medidata Solutions, Inc. (Medidata) announced that it has received the Patient Engagement App Challenge Prize (large organization category) at the 23rd Annual Partnerships in Clinical Trials Conference. Medidata stated that the award was attributed to the Company's unique mobile app, Engage, which was recognized for its potential to positively transform the clinical trial experience for study participants at a time when capturing the voice of the patient is becoming increasingly important. According to the Company, Engage is an easy-to-use, device-agnostic app that patients can access via their personal smartphones or other mobile devices. Glen de Vries, Medidata's President said, "By leveraging the smartphones, tablets and other mobile devices that study participants already have, we can provide continuous feedback as well as targeted messages to improve patient education, adherence, communications with their healthcare providers and outcomes." The full analyst notes on Medidata Solutions, Inc. are available to download free of charge at:

http://www.analystsreview.com/1199-MDSO-22Apr2014.pdf

--

Mettler-Toledo International, Inc. Analyst Notes 

On April 11, 2014, Mettler-Toledo International Inc.'s (Mettler-Toledo) stock declined slightly by 0.25% to end the day at $223.80, compared to the previous day's closing price at $224.37. The Company's stock went down 7.46% during the past six trading months, compared to the Dow Jones Industrial Average which went up 5.18% and to S&P 500 which rose 6.6% over the same trading period. The full analyst notes on Mettler-Toledo International, Inc. are available to download free of charge at:

http://www.analystsreview.com/1199-MTD-22Apr2014.pdf

--

WebMD Health Corp. Analyst Notes 

On April 9, 2014, WebMD Health Corp. (WebMD) announced that it will report its Q1 2014 financial results through a press release on Wednesday, April 30, 2014, at approximately 4:00 p.m. ET. The Company informed that it will also host a conference call at 4:45 p.m. ET on the same day to discuss the results. WebMD stated that the live webcast of the call and replay of the same will be available under the Investors Relations section of the Company's website. The full analyst notes on WebMD Health Corp. are available to download free of charge at:

http://www.analystsreview.com/1199-WBMD-22Apr2014.pdf

--

Fluidigm Corporation Analyst Notes 

Fluidigm Corp. (Fluidigm) posted on its events page that the Company will make an attendance to the Human Genome Meeting, which will be held on April 27, 2014 through April 30, 2014 at Geneva, Switzerland. The conference event is entitled "Genome Variation and Human Health," and will explore all aspects of genome exploration and its impact in international health. Additional information/updates regarding the said event will be made available through the Company's website. The full analyst notes on Fluidigm Corporation are available to download free of charge at:

http://www.analystsreview.com/1199-FLDM-22Apr2014.pdf

--

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

--

=============

EDITOR NOTES: 

• This is not company news. We are an independent source and our views do not reflect the companies mentioned.
• Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
• This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
• If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
• For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
• Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE 

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE 

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED 

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED